---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-016136"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2023-05-30T23:59:59+00:00"
generated_at: "2026-06-14T11:06:03.963514+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BIO-key receives Nasdaq non-compliance notice for late filings; plan due June 20

## Summary
- Nasdaq notified BIO-key on May 23, 2023 of non-compliance for failing to timely file Form 10-Q for Q1 2023.
- Company was already delinquent on Form 10-K for year ended Dec 31, 2022.
- Must submit compliance plan by June 20, 2023; if accepted, extension to Oct 16, 2023.
- No immediate impact on listing or trading of common stock on Nasdaq Capital Market.
- Form 12b-25 filed May 16, 2023 citing unreasonable effort to complete financial review.

## SEC filing metadata
- accession: 0001437749-23-016136
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2023-05-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774923016136/0001437749-23-016136-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774923016136/bkyi20230530_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-016136
- JSON: https://secwatch.observer/filing/0001437749-23-016136.json
- Plain text: https://secwatch.observer/filing/0001437749-23-016136.txt

## Key facts
- Listing & Compliance Notices
  BIO KEY INTERNATIONAL INC received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: May 23, 2023, BIO-key International, Inc. (the “Company”) received notice from The Nasdaq Stock Market, LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“SEC”), due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023 (the “Form 10-Q”). As previously reported, on April 18, 2023 the Company was notified by Nasdaq that is was not
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774923016136/0001437749-23-016136-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.